Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2012 16:30 ET | Source: Depomed, Inc.

Depomed Receives Notice of Paragraph IV Certification Against Patents for Gralise(TM)

MENLO PARK, Calif., Jan. 23, 2012 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced that it has received a Paragraph IV certification notice from Actavis Elizabeth LLC advising Depomed...
November 08, 2011 16:00 ET | Source: Depomed, Inc.

Depomed to Present at Lazard Capital Markets Healthcare Conference

MENLO PARK, Calif., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that its president and chief executive officer, Jim Schoeneck, will be presenting at the Lazard Capital...
November 01, 2011 16:01 ET | Source: Depomed, Inc.

Depomed Reports Third Quarter 2011 Financial Results

MENLO PARK, Calif., Nov. 1, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today reported financial results for the third quarter ended September 30, 2011 and provided an update on the company's...
October 26, 2011 16:00 ET | Source: Depomed, Inc.

Depomed to Announce Third Quarter 2011 Financial Results on Nov. 1, 2011

MENLO PARK, Calif., Oct. 26, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that it will release third quarter 2011 financial results after the market closes on Tuesday, Nov. 1,...
October 13, 2011 16:00 ET | Source: Depomed, Inc.

Depomed Announces Top-Line Results From Serada(R) Phase 3 Trial BREEZE 3 in Menopausal Hot Flashes

MENLO PARK, Calif., Oct. 13, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today announced top-line results from BREEZE 3, a Phase 3 trial evaluating the efficacy and safety of Serada®...
October 10, 2011 13:00 ET | Source: Depomed, Inc.

Depomed Announces New Once-Daily GRALISE(TM) Now Available for After-Shingles Pain

MENLO PARK, Calif., Oct. 10, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that GRALISE™ (gabapentin) tablets are now available as a new once-daily treatment for...
September 13, 2011 16:05 ET | Source: Depomed, Inc.

Depomed to Present at the UBS Global Life Sciences Conference

MENLO PARK, Calif., Sept. 13, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that its president and chief executive officer, Jim Schoeneck, will be presenting at the UBS Global...
August 31, 2011 16:05 ET | Source: Depomed, Inc.

Depomed to Present at the Stifel Nicolaus Healthcare Conference

MENLO PARK, Calif., Aug. 31, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that its president and chief executive officer, Jim Schoeneck, will be presenting at the Stifel...
August 01, 2011 16:03 ET | Source: Depomed, Inc.

Depomed Reports Second Quarter 2011 Financial Results

MENLO PARK, Calif., Aug. 1, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) today reported financial results for the second quarter ended June 30, 2011. Total revenues for the quarter were $21.2...
July 26, 2011 16:39 ET | Source: Depomed, Inc.

Depomed to Announce Second Quarter 2011 Financial Results on Aug. 1, 2011

MENLO PARK, Calif., July 26, 2011 (GLOBE NEWSWIRE) -- Depomed, Inc. (Nasdaq:DEPO) announced today that it will release second quarter 2011 financial results after the market closes on Monday, Aug. 1,...